Dieser Artikel kommt von finanztreff.de

Press, Release 24.04.2017 - 23:37:34

Press Release: Novartis expands global -2-

Press Release: Novartis expands global -2-. Press Release: Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the US and Canada Novartis International AG / Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in...

weiterlesen... @ finanztreff.de